NATCO Pharma opened sharply lower on Thursday after reporting a 37.75% drop in consolidated net profit to ₹132.4 crore for the December quarter, impacted by a decline in formulations exports. The stock tumbled 16.06% to an intraday low of ₹1,023 in early trade.
Comments
Post a Comment